Cite
MLA Citation
Nicole J Ullrich et al.. “A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.” Neuro-oncology, vol. 22, no. 10, 2020, pp. 1527–1535. http://access.bl.uk/ark:/81055/vdc_100116967979.0x000018